A. V. Zyryаnov

858 total citations
16 papers, 41 citations indexed

About

A. V. Zyryаnov is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, A. V. Zyryаnov has authored 16 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 3 papers in Rheumatology. Recurrent topics in A. V. Zyryаnov's work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (3 papers). A. V. Zyryаnov is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (3 papers). A. V. Zyryаnov collaborates with scholars based in Russia, Italy and United States. A. V. Zyryаnov's co-authors include Bohuslav Melichar, В. Б. Матвеев, Sangeeta Jethwa, Peter F.A. Mulders, Joaquim Bellmunt, Sergio Bracarda, Eva Fernebro, Rasa Jančiauskienė, Martin Gore and R. Jeroen A. van Moorselaar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of neurosurgery.

In The Last Decade

A. V. Zyryаnov

11 papers receiving 41 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. V. Zyryаnov Russia 3 26 15 14 14 6 16 41
Á. Montesa Pino Spain 5 26 1.0× 14 0.9× 11 0.8× 7 0.5× 13 2.2× 12 48
Bożena Sikora-Kupis Poland 3 32 1.2× 16 1.1× 24 1.7× 13 0.9× 14 2.3× 9 54
Chin-Chen Pan Taiwan 3 31 1.2× 8 0.5× 29 2.1× 16 1.1× 12 2.0× 4 50
Gökhan Çalık Türkiye 4 11 0.4× 20 1.3× 10 0.7× 9 0.6× 6 1.0× 10 35
Ahmad Nazran Fadzli Malaysia 4 23 0.9× 6 0.4× 16 1.1× 10 0.7× 4 0.7× 12 45
Alexander H. Song United States 2 16 0.6× 22 1.5× 17 1.2× 13 0.9× 5 0.8× 5 44
Tienan Yi China 5 15 0.6× 19 1.3× 22 1.6× 14 1.0× 6 1.0× 14 55
Jennifer Margrave United States 2 47 1.8× 12 0.8× 9 0.6× 18 1.3× 3 0.5× 3 55
Tasha Lea United States 2 26 1.0× 18 1.2× 15 1.1× 17 1.2× 6 1.0× 2 47
Miodrag Lazić Serbia 4 21 0.8× 9 0.6× 12 0.9× 4 0.3× 15 2.5× 19 48

Countries citing papers authored by A. V. Zyryаnov

Since Specialization
Citations

This map shows the geographic impact of A. V. Zyryаnov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Zyryаnov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Zyryаnov more than expected).

Fields of papers citing papers by A. V. Zyryаnov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Zyryаnov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Zyryаnov. The network helps show where A. V. Zyryаnov may publish in the future.

Co-authorship network of co-authors of A. V. Zyryаnov

This figure shows the co-authorship network connecting the top 25 collaborators of A. V. Zyryаnov. A scholar is included among the top collaborators of A. V. Zyryаnov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. V. Zyryаnov. A. V. Zyryаnov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zyryаnov, A. V., et al.. (2025). Uterine natural killer cells and pregnancy outcomes: mechanisms, biomarkers, and therapeutic targets. Obstetrics Gynecology and Reproduction.
2.
3.
4.
Zyryаnov, A. V., et al.. (2022). The Role of Digital Geography in the Development of Tourism and Tourist Activities. International Journal of Criminology and Sociology. 9. 2186–2191.
5.
Zyryаnov, A. V., et al.. (2021). Nordic Walking in Rehabilitation of Women with Stress Urinary Incontinence after Sling Operations. SHILAP Revista de lepidopterología. 20(6). 48–57.
6.
Zyryаnov, A. V., et al.. (2021). Multiparametric magnetic resonance imaging and combined prostate biopsy: opportunities, advantages and pitfalls. Medical Visualization. 25(2). 138–152.
7.
Zyryаnov, A. V., et al.. (2020). The epidemiology of neurogenic urination disciordeis dysfunction. Experimental and Сlinical Urology. 12(3). 25–33. 2 indexed citations
8.
Zyryаnov, A. V., et al.. (2019). Comparative analysis of adverse events using different methods of prostate biopsy. SHILAP Revista de lepidopterología. 15(1). 66–74. 1 indexed citations
9.
Zyryаnov, A. V., et al.. (2019). Long-term results of adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex in patients with high risk nonmuscle-invasive bladder cancer. SHILAP Revista de lepidopterología. 15(1). 92–100. 1 indexed citations
10.
Zyryаnov, A. V., et al.. (2019). Treatment of Lower Urinary Tract Neurogenic Dysfunction in Patients with Multiple Sclerosis. Effective Pharmacotherapy. 15(1). 22–30. 1 indexed citations
11.
Zyryаnov, A. V., et al.. (2018). The Role of Saturation Transperineal Biopsy in the Diagnosis of Prostate Cancer in the Era of Targeted Fusion Biopsies. SHILAP Revista de lepidopterología. 8(2). 27–32. 1 indexed citations
12.
Zyryаnov, A. V., et al.. (2018). Technical Features of Robot-Assisted Prostatectomy in Patients with Very Enlarged Prostates. SHILAP Revista de lepidopterología. 8(2). 33–40. 1 indexed citations
13.
Zyryаnov, A. V., et al.. (2017). The prognostic value of repeated prostate fusion biopsy. Cancer Urology. 13(3). 71–75. 1 indexed citations
14.
Zyryаnov, A. V., et al.. (2017). FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY. SHILAP Revista de lepidopterología. 5(4). 39–46. 3 indexed citations
15.
Melichar, Bohuslav, Sergio Bracarda, В. Б. Матвеев, et al.. (2013). A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN. Annals of Oncology. 24(9). 2396–2402. 24 indexed citations
16.
Melichar, Bohuslav, Sergio Bracarda, В. Б. Матвеев, et al.. (2011). BEVLiN: Prospective study of the safety and efficacy of first-line bevacizumab (BEV) plus low-dose interferon-α2a (IFN) in patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 29(15_suppl). 4546–4546. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Á. Montesa Pino Breakdown of academic impact, for papers by Bożena Sikora-Kupis Breakdown of academic impact, for papers by Chin-Chen Pan Breakdown of academic impact, for papers by Gökhan Çalık Breakdown of academic impact, for papers by Ahmad Nazran Fadzli Breakdown of academic impact, for papers by Alexander H. Song Breakdown of academic impact, for papers by Tienan Yi Breakdown of academic impact, for papers by Jennifer Margrave Breakdown of academic impact, for papers by Tasha Lea Breakdown of academic impact, for papers by Miodrag Lazić
Rankless by CCL
2026